Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -153.84% is 19% below its 5-year average of -129.75%, near the low end of its 5-year range (-194.11%–-56.70%).
4.08% below its 12-month average of -147.81%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -141.71%.
NET PROFIT MARGIN
-153.84%
NET PROFIT MARGIN AVG TTM
-147.81%
NET PROFIT MARGIN AVG 3Y
-125.11%
NET PROFIT MARGIN AVG 5Y
-129.75%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-4.08%
CURRENT VS 3Y AVG
-22.96%
CURRENT VS 5Y AVG
-18.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-59069.23%
vs the sector median at left
Personalis, Inc.
Market Cap
$1.71B
Net Profit Margin
-153.84%
TTM Avg
-147.81%
3Y Avg
-125.11%
5Y Avg
-129.75%
Market Cap
$1.71B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.70B
Net Profit Margin
-48438.40%
TTM Avg
-3458.57%
3Y Avg
-1747.85%
5Y Avg
-1747.85%
Market Cap
$1.73B
Net Profit Margin
-672.16%
TTM Avg
-753.31%
3Y Avg
-935.73%
5Y Avg
-797.48%
Market Cap
$1.74B
Net Profit Margin
0.89%
TTM Avg
-2.38%
3Y Avg
-5.83%
5Y Avg
-7.07%
Market Cap
$1.74B
Net Profit Margin
-5.12%
TTM Avg
-13.40%
3Y Avg
-37.66%
5Y Avg
-140.69%
Market Cap
$1.74B
Net Profit Margin
-7756.37%
TTM Avg
-3193.87%
3Y Avg
-2536.69%
5Y Avg
-2093.05%
Market Cap
$1.74B
Net Profit Margin
-21.25%
TTM Avg
-24.32%
3Y Avg
-26.63%
5Y Avg
-18.90%
Market Cap
$1.75B
Net Profit Margin
-2.63%
TTM Avg
-3.88%
3Y Avg
-2.58%
5Y Avg
-3.29%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Personalis, Inc. (PSNL) | $1.71B | -153.84% | -147.81% | -125.11% | -129.75% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -14.99% | -20.12% | -16.95% | -10.04% |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.70B | -48438.40% | -3458.57% | -1747.85% | -1747.85% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | -672.16% | -753.31% | -935.73% | -797.48% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 0.89% | -2.38% | -5.83% | -7.07% |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | -5.12% | -13.40% | -37.66% | -140.69% |
| Absci Corporation (ABSI)vs › | $1.74B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
| Novocure Ltd (NVCR)vs › | $1.74B | -21.25% | -24.32% | -26.63% | -18.90% |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | -2.63% | -3.88% | -2.58% | -3.29% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -636.99% | -743.17% | -743.17% | -743.17% |
Operating Margin
-126.4%
Net Profit Margin
-153.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -141.71% |
| 2026-03-31 | -194.11% |
| 2025-12-31 | -137.28% |
| 2025-09-30 | -149.38% |
| 2025-06-30 | -116.58% |
| 2025-03-31 | -76.44% |
| 2024-12-31 | -97.77% |
| 2024-09-30 | -152.04% |
| 2024-06-30 | -56.70% |
| 2024-03-31 | -66.42% |
| 2023-12-31 | -135.12% |
| 2023-09-30 | -159.47% |
| 2023-06-30 | -143.45% |
| 2023-03-31 | -151.96% |
| 2022-12-31 | -185.79% |
| 2022-09-30 | -178.30% |
| 2022-06-30 | -151.02% |
| 2022-03-31 | -185.26% |
| 2021-12-31 | -97.66% |
| 2021-09-30 | -79.38% |
| 2021-06-30 | -69.00% |
| 2021-03-31 | -59.40% |
| 2020-12-31 | -66.12% |
| 2020-09-30 | -48.17% |
| 2020-06-30 | -47.47% |
| 2020-03-31 | -47.70% |
| 2019-12-31 | -36.60% |
| 2019-09-30 | -40.14% |
| 2019-06-30 | -37.09% |
| 2019-03-31 | -40.39% |
| 2018-12-31 | -27.02% |
| 2018-09-30 | -31.24% |
| 2018-06-30 | -83.13% |
| 2018-03-31 | -129.08% |
